Cardioprotective Effect of Rutin Considering Cardiac Enzyme Level in Induced Myocardial Infarction

被引：0
作者：
Malaviya, Shailesh [1 ]
Bhalodia, Yagnik [1 ]
Vaghasiya, Jitendra [1 ]
Manek, Ravi [1 ]
Sheth, Navinchandra [2 ]
Jivani, Nurudin [1 ]
机构：
[1] Jodhpur Natl Univ, Jodhpur 342001, Rajasthan, India
[2] Saurashtra Univ, Dept Pharmaceut, Rajkot 360005, Gujarat, India
来源：
LATIN AMERICAN JOURNAL OF PHARMACY | 2011年 / 30卷 / 02期
关键词：
Glutathione; Malonylaldehyde; Myocardial infarction; Protein kinase C; Rutin; superoxide dismutase; HEART; ISOPROTERENOL; EVENTS;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The present study was designed to investigate effects of rutin on isoproterenol induced myocardial infarction (MI) by considering enzyme level in rats. Rats were treated with rutin contineously for 10 days (10 mg/kg/day, i.p.,); MI were induced by treating rats with isoproterenol for last 2 consecutive days (5.25 and 8 mg/kg, i.p). Protein kinase C (PKC), malonylaldehyde (MAL), Glutathione (GSH), superoxide dismutase (SOD) and survival rate were evaluated. Rutin enhanced survival rate evaluated at the end of experiment. Result shows significant decrease in level of PKC (P < 0.001) and MAL enzyme (P < 0.01) while elevation of GSH (P < 0.001) and SOD (P < 0.001) level in pretreated rutin + isoproterenol group and pretreated rutin group as compared to isoproterenol treated group indicates cardioprotective effect of rutin. The results indicate that Rutin significantly reduces myocardial infarction and emphasize the beneficial action in prevention of MI.
引用
收藏
页码：397 / 401
页数：5
相关论文
共 25 条
  • [1] [Anonymous], CHANGING HIST
  • [2] Pyruvate provides cardioprotection in the experimental model of myocardial ischemic reperfusion injury
    Arya, Dharamvir Singh
    Bansal, Pankaj
    Ojha, Shreesh Kumar
    Nandave, Mukesh
    Mohanty, Ipseeta
    Gupta, Suresh Kumar
    [J]. LIFE SCIENCES, 2006, 79 (01) : 38 - 44
  • [3] Bioflavonoid rescue of ascorbate at a membrane interface
    Bandy, B
    Bechara, EJH
    [J]. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 2001, 33 (04) : 269 - 277
  • [4] Renal function as a risk indicator for cardiovascular events in 3216 patients with manifest arterial disease
    Bax, Liesbeth
    Algra, Ale
    Mali, Willem P. Th. M.
    Edlinger, Michael
    Beutler, Jaap J.
    van der Graaf, Yolanda
    [J]. ATHEROSCLEROSIS, 2008, 200 (01) : 184 - 190
  • [5] Bloor SJ, 2001, METHOD ENZYMOL, V335, P3
  • [6] BRODDE OE, 1991, PHARMACOL REV, V43, P203
  • [7] Chun O.K., 2003, J AGR FOOD CHEM, V51
  • [8] Izar G., 1991, PHARM CHEM J, V25, P65
  • [9] Jovanovic SV, 2000, ANN NY ACAD SCI, V899, P326, DOI 10.1111/j.1749-6632.2000.tb06197.x
  • [10] Kleiner DH, 2006, J AM COLL CARDIOL, V48, P56
123